# Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence

> **NCT06939400** · — · NOT_YET_RECRUITING · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Glioblastoma Multiforme (GBM)

## Interventions

- **PROCEDURE:** Photodynamic therapy (PDT)
- **PROCEDURE:** GBM patients recevied traditional treatment options

## Key facts

- **NCT ID:** NCT06939400
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06939400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06939400, "Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06939400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*